Adyn helps women find the birth control that is best for them by assessing genetic risk for side effects and hormone levels. They have doctors available for telemedicine appointments to provide prescriptions for the appropriate contraceptive.
Finding the right birth control can require trial and error with many possible side effects for some people. This can include weight changes, bloating, headaches, and mood fluctuations. Certain types of contraception aren’t suitable for some people as they can increase the chance of severe side effects such as cancer and blood clots. Using guidelines and now science to find the right birth control from the start can make it a much safer and comfortable experience.
Adyn is a startup in the US with an early-access solution. They provide an at-home test kit which is returned to the lab by mail. This involves a saliva and finger-prick blood test. The lab assesses the patient’s genetic risk for side effects and analyses their hormone levels to make personalised recommendations. This includes coils, pills, patches and implants.
Adyn will make it easy for women to access the birth control that’s suited for them by offering telemedicine appointments directly through the platform. The doctor will go over the lab results and answer any questions before prescribing a contraceptive. The selected prescription is mailed directly to the patient’s door, so there is no need to go to a clinic or pharmacy in person.
Adyn will only be available in the US and do not yet have a launch date. The early-access waitlist is available here. A similar company is Pexxi in the UK, which uses a chatbot to gather physical and mental health information, with optional at-home genetic/hormone testing to choose the most appropriate pill.
“My research experiences combined with my personal odyssey with birth control inspired adyn. People on hormonal birth control suffer simply because the science is imprecise. At adyn we use big inclusive data sets to develop personalised medical treatment based on your unique hormonal and genetic profile. Adverse side effects should not interfere with my ability to conduct science or your ability to live your best life.” – Elizabeth Ruzzo, Founder